MEDIZINREPORT
Therapie von Leukämien bei Kindern: Optimierte Stammzelltransplantate
Dtsch Arztebl 2012; 109(16): A-808 / B-700 / C-696
| 1. | Klingebiel T, Cornish J, Labopin M, Locatelli F, et al.: Results and factors influencing outcome after fully haploidentical henatopoetic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia. Blood 2010; 115: 3437–46. CrossRef MEDLINE |
| 2. | Leung W, Campana D, Yank J, et al.: High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood 2011; 118: 223–30. CrossRef MEDLINE |
| 3. | Handgretinger R, Lang, P, Feuchtinger TF, Schumm, M, et al.: Transplantation of TcR αβ CD19 depletedstem cells from haploidentical donors: robusrt engrasftment and rapid immune reconstitution in children with high risk leukemia. 53rd ASH Annual Meeting 2011; Abstr. 1005. |
| 4. | Brehm C, Huenecke S, Quaiser A, et al.: IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study. PlOS One 2011; 11: e27351. CrossRef MEDLINE PubMed Central |
